Form 4 for TECH Bio-Techne
Accepted 2024-08-02 00:00:00 ET · period of report 2024-07-31 · accession 0001062993-24-014366 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-02 | 2024-07-31 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $81.97 | -9,479 | 39.9K | -19% | -$777.0K |
| D | 2024-08-02 | 2024-07-31 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $37.70 | +14.0K | 49.4K | +40% | +$527.8K |
| D | 2024-08-02 | 2024-07-31 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -14.0K | 13.4K | -51% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | F | D | 9,479 | $81.97 | 39,942 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-31 | M | A | 14,000 | $37.70 | 49,421 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-07-31 | M | D | 14,000 | $0.00 | 13,392 | D | $37.70 · — to 2025-05-01 | 14,000 Common Stock | (F1) Fully exercisable. |